| Style | Citing Format |
|---|---|
| MLA | Adel Mehraban MS, et al.. "Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial." Complementary Therapies in Clinical Practice, vol. 43, no. , 2021, pp. -. |
| APA | Adel Mehraban MS, Shirzad M, Ahmadianattari MM, Shakeri R, Taghizadeh Kashani LM, Tabarrai M, Shirbeigi L (2021). Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial. Complementary Therapies in Clinical Practice, 43(), -. |
| Chicago | Adel Mehraban MS, Shirzad M, Ahmadianattari MM, Shakeri R, Taghizadeh Kashani LM, Tabarrai M, Shirbeigi L. "Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial." Complementary Therapies in Clinical Practice 43, no. (2021): -. |
| Harvard | Adel Mehraban MS et al. (2021) 'Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial', Complementary Therapies in Clinical Practice, 43(), pp. -. |
| Vancouver | Adel Mehraban MS, Shirzad M, Ahmadianattari MM, Shakeri R, Taghizadeh Kashani LM, Tabarrai M, et al.. Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial. Complementary Therapies in Clinical Practice. 2021;43():-. |
| BibTex | @article{ author = {Adel Mehraban MS and Shirzad M and Ahmadianattari MM and Shakeri R and Taghizadeh Kashani LM and Tabarrai M and Shirbeigi L}, title = {Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial}, journal = {Complementary Therapies in Clinical Practice}, volume = {43}, number = {}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Adel Mehraban MS AU - Shirzad M AU - Ahmadianattari MM AU - Shakeri R AU - Taghizadeh Kashani LM AU - Tabarrai M AU - Shirbeigi L TI - Effect of Rose Oil on Gastroesophageal Reflux Disease in Comparison With Omeprazole: A Double-Blind Controlled Trial JO - Complementary Therapies in Clinical Practice VL - 43 IS - SP - EP - PY - 2021 ER - |